{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/18/3314101/0/en/Denali-Therapeutics-Enters-Agreement-to-Sell-Rare-Pediatric-Disease-Priority-Review-Voucher-for-195-Million.html", "message": "News view counter 806928 successfully enlarged"}